Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5

• Published in: Oncology reports Vol. 45; no. 2; pp. 501 - 512
• Main Authors: Zhu, Zheng, Wu, Qiyong, Zhang, Ming, Tong, Jichun, Zhong, Bin, Yuan, Kai
• Format: Journal Article
• Language: English
• Published: Greece Spandidos Publications 01.02.2021; Spandidos Publications UK Ltd; D.A. Spandidos
• Subjects: Analysis; Animal experimentation; Binding sites; Cancer therapies; Cell adhesion & migration; Chemotherapy; Fibroblast growth factors; Health savings accounts; Hospitals; Immunohistochemistry; Lung cancer; Lung cancer, Non-small cell; Lung cancer, Small cell; Medical prognosis; Radiation therapy; RNA; Scientific equipment and supplies industry; Tumors; United States; China
• ISSN: 1021-335X; 1791-2431; 1791-2431
• DOI: 10.3892/or.2020.7899

Hsa_circ_0016760 expression has been reported to be increased in non‑small cell lung cancer (NSCLC). The present study was designed to explore the role and mechanism of hsa_circ_0016760 in regulating NSCLC progression. In total, 60NSCLC patients were followed‑up for 60 months after surgery. Hsa_circ...